Topics

"Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection" Drugs and Medication Database

13:41 EST 9th December 2019 | BioPortfolio

Here are the most relevant "Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection" Drugs and Medications that we have found in our database.

More Information about "Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection" on BioPortfolio

We have published hundreds of Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection news stories on BioPortfolio along with dozens of Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection Clinical Trials and PubMed Articles about Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection Companies in our database. You can also find out about relevant Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection Drugs and Medications on this site too.

Showing "Biopsies Imperfect Gold Standard Diagnosing Post Transplant Rejection" Drugs and Medications 1–25 of 132

Probably Relevant

Myfortic [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use MYFORTIC safely and effectively. See full prescribing information for MYFORTIC. MYFORTIC® (mycophenolic acid) delayed-release tablets, for oral use Initial U.S. Approval: 2004

Mycophenolic acid [apotex corp]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. MYCOPHENOLIC ACID delayed-release tablets,

Mycophenolic acid [major pharmaceuticals]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. MYCOPHENOLIC ACID delayed-release tablets,

Mycophenolic acid [american health packaging]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. MYCOPHENOLIC ACID delayed-release tablets,

Mycophenolic acid [golden state medical supply, inc.]

MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. M

Mycophenolic acid [accord healthcare inc.]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED RELEASE TABLETS. MYCOPHENOLIC ACID delayed release tablets,

Mycophenolate mofetil [cadila healthcare limited]

These highlights do not include all the information needed to use Mycophenolate Mofetil for Injection, USP safely and effectively. See full prescribing information for Mycophenolate Mofetil for Injection, USP Initial U.S. Approval: 1995

Mycophenolate mofetil [zydus pharmaceuticals (usa) inc.]

These highlights do not include all the information needed to use Mycophenolate Mofetil for Injection, USP safely and effectively. See full prescribing information for Mycophenolate Mofetil for Injection, USP Initial U.S. Approval: 1995

Sirolimus [american health packaging]

These highlights do not include all the information needed to use SIROLIMUS TABLETS safely and effectively. See full prescribing information for SIROLIMUS TABLETS. SIROLIMUS tablets, for oral use Initial U.S. Approval: 1999

Mycophenolate mofetil [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use MYCOPHENOLATE MOFETIL CAPSULES safely and effectively. See full prescribing information for MYCOPHENOLATE MOFETIL CAPSULES. MYCOPHENOLATE MOFETIL capsules, for oral use Initial U.S. Appr

Sirolimus [greenstone llc]

These highlights do not include all the information needed to use SIROLIMUS safely and effectively. See full prescribing information for SIROLIMUS. SIROLIMUS tablets, for oral use Initial U.S. Approval: 1999

Mycophenolate mofetil [sandoz inc]

These highlights do not include all the information needed to use MYCOPHENOLATE MOFETIL safely and effectively. See full prescribing information for MYCOPHENOLATE MOFETIL.MYCOPHENOLATE mofetil capsules, for oral useMYCOPHENOLATE mofetil tablets, for oral

Cellcept [genentech, inc.]

These highlights do not include all the information needed to use CELLCEPT safely and effectively. See full prescribing information for CELLCEPT CELLCEPT (mycophenolate mofetil) capsules, for oral useCELLCEPT (mycophenolate mofetil) tablets, for oral useC

Possibly Relevant

Thymoglobulin [genzyme corporation]

These highlights do not include all the information needed to use THYMOGLOBULIN safely and effectively. See full prescribing information for THYMOGLOBULIN. THYMOGLOBULIN (anti-thymocyte globulin [rabbit]) for intravenous use Initial U.S. Approval: 1998

Tacrolimus [cardinal health]

Tacrolimus Capsules

Prograf [rebel distributors corp]

PROGRAF®tacrolimus capsulestacrolimus injection (for intravenous infusion only)

Nulojix [e.r. squibb & sons, l.l.c.]

These highlights do not include all the information needed to use NULOJIX safely and effectively. See full prescribing information for NULOJIX. NULOJIX (belatacept) for injection, for intravenous useInitial U.S. Approval: 2011

Mycophenolate mofetil [ascend laboratories, llc]

Mycophenolate Mofetil for Oral Suspension USP

Cyclosporine [mayne pharma inc.]

Cyclosporine Capsules, USP [MODIFIED] (Soft Gelatin) Cyclosporine ORAL SOLUTION, USP [MODIFIED]

Gengraf [abbvie inc.]

GENGRAF Capsules (cyclosporine capsules, USP [MODIFIED])

Gengraf [abbvie inc.]

GENGRAF ORAL SOLUTION(cyclosporine oral solution, USP [MODIFIED])

Tacrolimus [sandoz inc]

These highlights do not include all the information needed to use TACROLIMUS CAPSULES safely and effectively. See full prescribing information for TACROLIMUS CAPSULES. TACROLIMUS capsules, for oral useInitial U.S. Approval: 1994

Lansoprazole [direct rx]

LANSOPRAZOLE

Simulect [novartis pharmaceuticals corporation]

Simulect (basiliximab) For Injection Rx only Prescribing Information

Azathioprine [mylan pharmaceuticals inc.]



Quick Search